ESLA

Estrella Immunopharma (ESLA)

About Estrella Immunopharma (ESLA)

Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.

Details

Daily high

$1.88

Daily low

$1.60

Price at open

$1.77

52 Week High

$3.15

52 Week Low

$0.73

Market cap

68.4M

Dividend yield

0.00%

Volume

111,228

Avg. volume

159,746

P/E ratio

-4.89

Estrella Immunopharma News